AZ and ICL link to research respiratory diseases

22nd December 2017 Uncategorised 0

AstraZeneca and Imperial College London have announced plans to work together on investigating the scientific mechanisms and underlying drivers of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

More: AZ and ICL link to research respiratory diseases
Source: News